# ArriVent BioPharma, Inc.: filings

AVBP · Nasdaq · CIK 1868279 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/avbp.md) · [Financials](/companies/avbp/financials.md) · [Filings](/companies/avbp/filings.md) · [Insiders](/companies/avbp/insiders.md)

## Reports and events: 52 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 31, 4 30, 3 14, SCHEDULE 13G/A 9, 10-Q 8, SC 13G 6, SCHEDULE 13G 6, CORRESP 4, UPLOAD 4, 10-K 3, 424B5 3, DRS/A 3, DRSLTR 3, S-8 3, 8-K/A 2, ARS 2, D 2, DEF 14A 2, DEFA14A 2, S-1/A 2, SCHEDULE 13D/A 2, SEC STAFF LETTER 2, 424B4 1, 8-A12B 1, CERT 1, D/A 1, DRS 1, EFFECT 1, S-1 1, S-1MEF 1, S-3ASR 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 06:00 ET | [8-K](/filings/0001104659-26-118550.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-118550 |
| 2026-10-19 | 08:08 ET | [8-K](/filings/0001104659-26-116736.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-116736 |
| 2026-10-13 | 06:03 ET | [8-K](/filings/0001104659-26-115161.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-115161 |
| 2026-10-08 | 18:39 ET | [SCHEDULE 13D/A](/filings/0000947871-26-000931.md) | Ownership report, active investor, amended | 0000947871-26-000931 |
| 2026-10-06 | 08:07 ET | [8-K](/filings/0001104659-26-113898.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-113898 |
| 2026-08-12 | 16:20 ET | [10-Q](/filings/0001104659-26-094902.md) | Quarterly report, period 2026-06-30 | 0001104659-26-094902 |
| 2026-08-12 | 16:07 ET | [8-K](/filings/0001104659-26-094869.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-094869 |
| 2026-06-22 | 16:01 ET | [8-K](/filings/0001104659-26-076352.md) | 5.07 Shareholder vote results | 0001104659-26-076352 |
| 2026-05-11 | 16:43 ET | [8-K](/filings/0001104659-26-058706.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-058706 |
| 2026-05-11 | 16:08 ET | [10-Q](/filings/0001104659-26-058650.md) | Quarterly report, period 2026-03-31 | 0001104659-26-058650 |
| 2026-05-11 | 16:05 ET | [8-K](/filings/0001104659-26-058638.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-058638 |
| 2026-04-28 | 16:08 ET | [DEF 14A](/filings/0001104659-26-050337.md) | Proxy statement, period 2026-06-18 | 0001104659-26-050337 |
| 2026-03-17 | 17:05 ET | [8-K](/filings/0001104659-26-029588.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-029588 |
| 2026-03-05 | 16:18 ET | [10-K](/filings/0001104659-26-024127.md) | Annual report, period 2025-12-31 | 0001104659-26-024127 |
| 2026-03-05 | 16:11 ET | [8-K](/filings/0001104659-26-024112.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-024112 |
| 2025-11-10 | 08:02 ET | [10-Q](/filings/0001104659-25-108847.md) | Quarterly report, period 2025-09-30 | 0001104659-25-108847 |
| 2025-11-10 | 08:00 ET | [8-K](/filings/0001104659-25-108839.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-108839 |
| 2025-09-09 | 08:00 ET | [8-K](/filings/0001558370-25-011954.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-011954 |
| 2025-08-13 | 19:43 ET | [SCHEDULE 13D/A](/filings/0000947871-25-000764.md) | Ownership report, active investor, amended | 0000947871-25-000764 |
| 2025-08-11 | 08:01 ET | [10-Q](/filings/0001558370-25-010975.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010975 |
| 2025-08-11 | 08:00 ET | [8-K](/filings/0001558370-25-010974.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-010974 |
| 2025-07-21 | 08:08 ET | [8-K](/filings/0001104659-25-069169.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-069169 |
| 2025-07-02 | 17:00 ET | [8-K](/filings/0001104659-25-065386.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-065386 |
| 2025-06-23 | 07:06 ET | [8-K](/filings/0001104659-25-061375.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-061375 |
| 2025-06-20 | 16:14 ET | [8-K](/filings/0001104659-25-061165.md) | 5.07 Shareholder vote results | 0001104659-25-061165 |
| 2025-05-12 | 09:35 ET | [10-Q](/filings/0001558370-25-007276.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007276 |
| 2025-05-12 | 08:00 ET | [8-K](/filings/0001558370-25-007259.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-007259 |
| 2025-04-28 | 16:16 ET | [DEF 14A](/filings/0001104659-25-040214.md) | Proxy statement, period 2025-06-18 | 0001104659-25-040214 |
| 2025-04-28 | 08:15 ET | [8-K](/filings/0001104659-25-039799.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-039799 |
| 2025-03-13 | 17:00 ET | [8-K](/filings/0001558370-25-002912.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001558370-25-002912 |
| 2025-03-03 | 07:21 ET | [8-K](/filings/0001558370-25-002002.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-002002 |
| 2025-03-03 | 07:18 ET | [10-K](/filings/0001558370-25-001999.md) | Annual report, period 2024-12-31 | 0001558370-25-001999 |
| 2025-01-22 | 19:21 ET | [8-K](/filings/0001104659-25-004967.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-004967 |
| 2024-11-14 | 08:01 ET | [10-Q](/filings/0001558370-24-015624.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015624 |
| 2024-11-14 | 08:00 ET | [8-K](/filings/0001558370-24-015622.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-015622 |
| 2024-09-09 | 12:15 ET | [8-K](/filings/0001104659-24-098059.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-098059 |
| 2024-08-14 | 16:15 ET | [10-Q](/filings/0001558370-24-012236.md) | Quarterly report, period 2024-06-30 | 0001558370-24-012236 |
| 2024-08-14 | 16:05 ET | [8-K](/filings/0001558370-24-012223.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-012223 |
| 2024-07-09 | 17:05 ET | [8-K/A](/filings/0001104659-24-078587.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-078587 |
| 2024-07-09 | 17:03 ET | [8-K/A](/filings/0001104659-24-078585.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-078585 |
| 2024-06-05 | 07:15 ET | [8-K](/filings/0001104659-24-068503.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-068503 |
| 2024-05-16 | 16:11 ET | [8-K](/filings/0001104659-24-062528.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-062528 |
| 2024-05-08 | 08:01 ET | [10-Q](/filings/0001558370-24-007197.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007197 |
| 2024-05-08 | 08:00 ET | [8-K](/filings/0001558370-24-007196.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-007196 |
| 2024-04-22 | 16:10 ET | [8-K](/filings/0001104659-24-049988.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-049988 |
| 2024-03-28 | 17:14 ET | [10-K](/filings/0001558370-24-004280.md) | Annual report, period 2023-12-31 | 0001558370-24-004280 |
| 2024-03-28 | 16:15 ET | [8-K](/filings/0001104659-24-040532.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-040532 |
| 2024-02-05 | 16:42 ET | [SC 13D](/filings/0000947871-24-000091.md) | Ownership report, active investor | 0000947871-24-000091 |
| 2024-01-30 | 16:05 ET | [8-K](/filings/0001104659-24-008228.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-008228 |
| 2024-01-23 | 17:18 ET | [S-1/A](/filings/0001104659-24-005933.md) | Registration statement, amended | 0001104659-24-005933 |

Page 1 of 2. [Older](/companies/avbp/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 06:02 ET. No prices; not investment advice.